ADPKD symptoms — what they mean and when to take action

High blood pressure — the earliest and most impactful symptom

Why it happens: growing cysts compress blood vessels within the kidney, activating the renin-angiotensin-aldosterone system (RAAS). This raises blood pressure even when eGFR is still normal. It can start in childhood in some cases.

Why it matters so much: uncontrolled hypertension is one of the strongest drivers of faster ADPKD progression. Treating it is the single most impactful thing most people with ADPKD can do outside of tolvaptan candidacy.

Target: KDIGO 2025 recommends < 130/80 mmHg for most adults with ADPKD. Younger adults with significant risk may benefit from lower targets — discuss with your nephrologist.

• Home blood pressure monitoring (morning and evening) gives more useful data than occasional office readings
• ACE inhibitors (eg. lisinopril) or ARBs (eg. losartan) are first-line — they also reduce kidney filtration pressure
• Low sodium intake amplifies the benefit of these drugs

Flank and abdominal pain

Pain is the most common ADPKD symptom after hypertension, affecting 60% of people at some point. It ranges from mild chronic discomfort to acute severe episodes.

Common causes of pain in ADPKD

• Cyst growth pressure — dull, chronic ache from kidneys pressing on surrounding structures. Often worst after prolonged sitting or on the affected side.
• Cyst haemorrhage (bleeding into a cyst) — sudden, sharp flank pain, sometimes with visible blood in urine. Usually self-limiting over 3–7 days. Rest and hydration help; most do not need hospitalisation.
• Cyst rupture — pain similar to haemorrhage; fluid escapes into surrounding tissue. Usually resolves without intervention.
• Kidney stone — colicky (wave-like) severe pain radiating from flank to groin, often with blood in urine. Needs assessment to distinguish from other causes.
• Cyst infection — fever, localised pain, tenderness. Requires antibiotics — see urgent care.

Hematuria (blood in urine)

Visible blood in urine (gross hematuria) occurs in about 35–50% of ADPKD patients at some point in their lifetime. The most common cause is a cyst haemorrhage leaking into the collecting system.

What usually happens: it appears suddenly (often after exercise or a bump), clears over 3–7 days, and does not indicate a serious acute event. Most episodes resolve with rest, increased fluid intake, and pain management if needed.

When to be more concerned:

• Lasts more than 7 days
• Associated with fever (infection until proven otherwise)
• Passing blood clots (can cause obstruction)
• First episode after age 50 (different differential diagnosis considerations)
• Severe pain with bleeding

Always tell your nephrologist about any episode of visible blood, even if it resolved. Document the date, duration, and associated symptoms.

UTIs and cyst infection

People with ADPKD have a higher rate of urinary tract infections, especially women. More concerning: cyst infections, where bacteria seed inside a cyst.

Cyst infections are hard to diagnose (standard urine cultures may be negative if the infection is in an isolated cyst) and hard to treat (many antibiotics penetrate cysts poorly). Fat-soluble antibiotics like ciprofloxacin and trimethoprim have better cyst penetration.

Signs of possible cyst infection: fever, flank pain or tenderness, feeling unwell — without a clear UTI on standard testing. This warrants urgent evaluation.

Kidney stones

ADPKD increases kidney stone risk to about 20–36% lifetime prevalence, compared to roughly 9% in the general population. Uric acid stones are especially common due to low urinary pH.

Classic presentation: sudden severe flank pain radiating to the groin, nausea, and blood in urine. Pain is typically colicky (comes in waves) as the stone moves through the ureter.

Prevention: adequate hydration, lower sodium, lower animal protein, limit high-oxalate foods if you have oxalate stones. Your urologist can advise based on your stone type.

Intracranial aneurysm risk

Around 9–12% of people with ADPKD have an intracranial aneurysm (ICA), compared to ~3% in the general population. PKD1 mutations and family history of ICA increase risk further.

Screening: MRA (MRI angiography) is recommended if you have a family history of ICA or ruptured aneurysm, or work in a high-risk profession (pilot, diver). Routine screening for everyone is not standard — discuss your individual risk with your neurologist and nephrologist.

Symptoms do not directly map to progression speed

One of the most important things to understand about ADPKD symptoms: how much you feel does not reliably predict how fast your kidneys are declining.

• Some people with large, fast-growing kidneys have minimal pain for years
• Some people with significant pain and bloating have slower-than-average progression
• Gross hematuria episodes do not predict faster or slower progression
• The most accurate progression assessment comes from eGFR trends and kidney volume (Mayo Classification) — not symptom severity

This means: do not catastrophise symptoms, and do not dismiss them either. Report them to your team. Use the evidence tools (labs, imaging, risk classification) to understand your actual trajectory.